title: Diagnostic capacity and antimalarial availability in Papua New Guinea before the introduction of a revised national malaria treatment protocol.
abstract: BACKGROUND
  Papua New Guinea (PNG) introduced a revised national malaria treatment protocol (NMTP) in late 2011. Successful implementation of the revised protocol requires all health facilities in PNG to have reliable access to microscopy or malaria rapid diagnostic kits as well as a reliable supply of all recommended first-line medications. This paper presents findings from a study that sought to assess the availability of microscopy, malaria rapid diagnostic kits and recommended first-line antimalarial medication in Papua New Guinean health facilities across the country before the introduction of the revised treatment protocol.
  
  
  METHODS
  A country-wide cross-sectional survey of 79 randomly selected health centres, health subcentres and aid posts. Data were collected via an interviewer-administered questionnaire completed with the officer in charge of participating health facilities.
  
  
  RESULTS
  Overall, 15% of surveyed health facilities had unexpired rapid diagnostic test (RDT) in stock or working microscopy available. A recommended first-line antimalarial for uncomplicated malaria was available in 85% of health facilities. The preferred first-line antimalarial combination for treating severe malaria was present in 42% of health facilities, although 68% had the capacity to provide either the preferred or recommended substitute first-line medication for severe malaria. The total number of health workers employed in the 79 surveyed health facilities was 443, only 3 of whom were medical doctors.
  
  
  CONCLUSIONS
  Our findings indicate that diagnostic capacity was low in Papua New Guinean health facilities before the introduction of the new NMTP and that access to recommended first-line antimalarial medication was variable. Substantial improvements in diagnostic capacity and antimalarial procurement and distribution will need to be made if the revised protocol is to be adhered to.
authors.forename: Serah F
authors.initials: SF
authors.lastname: Kurumop
authors.forename: Justin
authors.initials: J
authors.lastname: Pulford
authors.forename: Ivo
authors.initials: I
authors.lastname: Mueller
authors.forename: Peter M
authors.initials: PM
authors.lastname: Siba
authors.forename: Manuel W
authors.initials: MW
authors.lastname: Hetzel
mesh_terms: D000962:Antimalarials / Q000627:therapeutic use*; D002985:Clinical Protocols; D006291:Health Policy; D006297:Health Services Accessibility; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D010219:Papua New Guinea
chemical_list: D000962:Antimalarials